p.P339T | TCGA-15-1446 | GBM | TCGA | LVIFPE | LIG_APCC_ABBA_1 | 326:331 | Mutation substituting flanking lysine | 0.2222 |
p.V324M | TCGA-23-1114 | OV | TCGA | LVIFPE | LIG_APCC_ABBA_1 | 326:331 | Mutation rewiring degron network | 0.2778 |
p.S319F | TCGA-5L-AAT1 | BRCA | TCGA | LVIFPE | LIG_APCC_ABBA_1 | 326:331 | Mutation rewiring degron network | 0.1389 |
p.E224K | TCGA-A5-A2K7 | UCEC | TCGA | IEVHVE | LIG_APCC_ABBA_1 | 209:214 | Mutation rewiring degron network | 0.0556 |
p.G328R | TCGA-AA-3833 | COAD | TCGA | LVIFPE | LIG_APCC_ABBA_1 | 326:331 | Mutation altering degron motif | 0.7568 |
p.G328R | SIDM01016 | T-Lymphoblastic Leukemia | GDSC | LVIFPE | LIG_APCC_ABBA_1 | 326:331 | Mutation altering degron motif | 0.7568 |
p.G328R | SIDM01263 | T-Lymphoblastic Leukemia | GDSC | LVIFPE | LIG_APCC_ABBA_1 | 326:331 | Mutation altering degron motif | 0.7568 |
p.G328R | Jurkat | haematopoietic and lymphoid tissue | COSMIC | LVIFPE | LIG_APCC_ABBA_1 | 326:331 | Mutation altering degron motif | 0.7568 |
p.R216H | TCGA-AP-A056 | UCEC | TCGA | IEVHVE | LIG_APCC_ABBA_1 | 209:214 | Mutation rewiring degron network | 0.2778 |
p.D335N | TCGA-AP-A0LM | UCEC | TCGA | LVIFPE | LIG_APCC_ABBA_1 | 326:331 | Mutation rewiring degron network | 0.2222 |
p.I203V | TCGA-BR-6706 | STAD | TCGA | IEVHVE | LIG_APCC_ABBA_1 | 209:214 | Mutation rewiring degron network | 0.1667 |
p.C210F | TCGA-DD-AACV | LIHC | TCGA | IEVHVE | LIG_APCC_ABBA_1 | 209:214 | Mutation altering degron motif | 0.7108 |
p.G328E | TCGA-DF-A2KU | UCEC | TCGA | LVIFPE | LIG_APCC_ABBA_1 | 326:331 | Mutation altering degron motif | 0.7199 |
p.G328V | TCGA-DU-7294 | LGG | TCGA | LVIFPE | LIG_APCC_ABBA_1 | 326:331 | Mutation altering degron motif | 0.7532 |
p.R334H | TCGA-E6-A1LX | UCEC | TCGA | LVIFPE | LIG_APCC_ABBA_1 | 326:331 | Mutation rewiring degron network | 0.25 |
p.V316I | TCGA-EY-A212 | UCEC | TCGA | LVIFPE | LIG_APCC_ABBA_1 | 326:331 | Mutation rewiring degron network | 0.0556 |
p.Q204E | TCGA-XF-AAML | BLCA | TCGA | IEVHVE | LIG_APCC_ABBA_1 | 209:214 | Mutation rewiring degron network | 0.1944 |
p.L340F | DO227935 | BRCA | ICGC | LVIFPE | LIG_APCC_ABBA_1 | 326:331 | Mutation rewiring degron network | 0.0833 |
p.R204C | DO7962 | COAD | ICGC | IEVHVE | LIG_APCC_ABBA_1 | 209:214 | Mutation rewiring degron network | 0.1944 |
p.Q324H | DO8264 | COAD | ICGC | LVIFPE | LIG_APCC_ABBA_1 | 326:331 | Mutation rewiring degron network | 0.2778 |
p.R204S | DO47491 | SKCM | ICGC | IEVHVE | LIG_APCC_ABBA_1 | 209:214 | Mutation rewiring degron network | 0.1944 |
p.M217I | DO38006 | SKCM | ICGC | IEVHVE | LIG_APCC_ABBA_1 | 209:214 | Mutation rewiring degron network | 0.25 |
p.I208M | DO43186 | UCEC | ICGC | IEVHVE | LIG_APCC_ABBA_1 | 209:214 | Mutation rewiring degron network | 0.3056 |
p.K222N | DO43907 | UCEC | ICGC | IEVHVE | LIG_APCC_ABBA_1 | 209:214 | Mutation substituting flanking lysine | 0.2222 |
p.L337M | ACH-000608 | Ovarian Cancer | CCLE | LVIFPE | LIG_APCC_ABBA_1 | 326:331 | Mutation rewiring degron network | 0.1667 |
p.E209D | ACH-000786 | Lymphoma | CCLE | IEVHVE | LIG_APCC_ABBA_1 | 209:214 | Mutation altering degron motif | 0.6758 |
p.E209D | Daudi | haematopoietic and lymphoid tissue | COSMIC | IEVHVE | LIG_APCC_ABBA_1 | 209:214 | Mutation altering degron motif | 0.6758 |
p.R323Q | ACH-000994 | Endometrial/Uterine Cancer | CCLE | LVIFPE | LIG_APCC_ABBA_1 | 326:331 | Mutation rewiring degron network | 0.25 |
p.R323Q | ACH-000998 | Colon/Colorectal Cancer | CCLE | LVIFPE | LIG_APCC_ABBA_1 | 326:331 | Mutation rewiring degron network | 0.25 |
p.K207M | MSTO-211H | pleura | COSMIC | IEVHVE | LIG_APCC_ABBA_1 | 209:214 | Mutation rewiring degron network | 0.2778 |